Stifel Maintains Neurogene(NGNE.US) With Buy Rating, Maintains Target Price $46

Futu NewsNov 21 21:31 · Ratings

Express News | Neurogene Inc : Stifel Cuts Target Price to $46 From $60

BreakingsNov 21 20:21

Stifel Maintains Neurogene(NGNE.US) With Buy Rating, Raises Target Price to $46

Futu NewsNov 21 11:31 · Ratings

TD Cowen Maintains Neurogene(NGNE.US) With Buy Rating

Futu NewsNov 21 08:31 · Ratings

Neurogene's Resilient Clinical Progress and Strong Financial Position Support Buy Rating

TipRanksNov 21 08:15 · Ratings

Neurogene Is Maintained at Outperform by BMO Capital

Dow JonesNov 20 22:17 · Ratings